Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature

European Urology

Volumn 50, Issue 6, 2006, Pages 1176-1182

  Fahmy, Nader M ^a   Mahmud, Salaheddin ^a,b   Aprikian, Armen G ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bladder cancer; Cystectomy; Outcome assessment; Treatment delay

Indexed keywords

BLADDER CANCER; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYSTECTOMY; DISEASE SEVERITY; HEMATURIA; HUMAN; INDEPENDENT VARIABLE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; THERAPY DELAY; TREATMENT OUTCOME; TUMOR RECURRENCE;

CYSTECTOMY; DISEASE PROGRESSION; HUMANS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 33750604607     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.05.046     Document Type: Review

References (27)

1. Canadian Cancer Society, National Cancer Institute of Canada, Statistics Canada, Provincial/Territorial Cancer Registries, Public Health Agency of Canada. Canadian cancer statistics; 2005.
2. Raghavan D., Quinn D., Skinner D.G., and Stein J.P. Surgery and adjunctive chemotherapy for invasive bladder cancer. Surg Oncol 11 (2002) 55-63
3. Chang S.S., and Cookson M.S. Radical cystectomy for bladder cancer: the case for early intervention. Urol Clin North Am 32 (2005) 147-155
4. Simunovic M., Gagliardi A., McCready D., Coates A., Levine M., and DePetrillo D. A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ 165 (2001) 421-425
5. May M., Nitzke T., Helke C., Vogler H., and Hoschke B. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Scand J Urol Nephrol 38 (2004) 231-235
6. Sanchez-Ortiz R.F., Huang W.C., Mick R., Van Arsdalen K.N., Wein A.J., and Malkowicz S.B. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169 (2003) 110-115 discussion 115
7. Cookson M. RE: treatment delay and prognosis in invasive bladder cancer [editorial comment]. J Urol 174 (2005) 1781
8. Smith Jr. J.A. RE: an interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma [editorial comment]. J Urol 169 (2003) 115
9. Chahal R., and Harrison S.C. RE: an interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma [letter to editor]. J Urol 170 (2003) 1327 author reply 1327
10. Erickson D., Kunselman A., and Bentley C. RE: an interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma [letter to editor]. J Urol 170 (2003) 1326-1327 author reply 1327
11. Chahal R., Sundaram S.K., Iddenden R., Forman D.F., Weston P.M., and Harrison S.C. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol 43 (2003) 246-257
12. Chang S.S., Hassan J.M., Cookson M.S., Wells N., and Smith Jr. J.A. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170 (2003) 1085-1087
13. Gulliford M.C., Petruckevitch A., and Burney P.G. Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. BMJ 303 (1991) 437-440
14. Hara I., Miyake H., Hara S., et al. Optimal timing of radical cystectomy for patients with invasive transitional cell carcinoma of the bladder. Jpn J Clin Oncol 32 (2002) 14-18
15. Hautmann R.E., and Paiss T. Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy?. J Urol 159 (1998) 1845-1850
16. Liedberg F., Anderson H., Mansson A., and Mansson W. Diagnostic delay and prognosis in invasive bladder cancer. Scand J Urol Nephrol 37 (2003) 396-400
17. Liedberg F., Anderson H., and Mansson W. Treatment delay and prognosis in invasive bladder cancer. J Urol 174 (2005) 1777-1781 discussion 1781
18. Mahmud S.M., Fong B., Fahmy N., Tanguay S., and Aprikian A.G. Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in quebec: a population based study. J Urol 175 (2006) 78-83
19. Mommsen S., Aagaard J., and Sell A. Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol 17 (1983) 163-167
20. Wallace D.M., Bryan R.T., Dunn J.A., Begum G., and Bathers S. Delay and survival in bladder cancer. BJU Int 89 (2002) 868-878
21. Wallace D.M., and Harris D.L. Delay in treating bladder tumours. Lancet 19 (1965) 332-334
22. Hornak M., and Bardos A. Biologic characteristics of invasive bladder cancer: is there a difference between primary and progressive tumours?. Rozhl Chir 83 (2004) 648-650
23. Dickinson A.J., Howe K., Bedford C., Sanders T., Prentice A., and Sibley G.N. A retrospective study of the investigation and management of muscle-invasive bladder cancer in the South West Region. Br J Urol 77 (1996) 70-75
24. Stower M.J. Delays in diagnosing and treating bladder cancer. Br Med J (Clin Res Ed) 296 (1988) 1228-1229
25. Turner A.G., Hendry W.F., Williams G.B., and Wallace D.M. A haematuria diagnostic service. Br Med J 2 (1977) 29-31
26. Paul A.B., Collie D.A., Wild S.R., and Chisholm G.D. An integrated haematuria clinic. Br J Clin Pract 47 (1993) 128-130
27. Bishop M.C. The dangers of a long urological waiting list. Br J Urol 65 (1990) 433-440